The Dyslipidemia Market: Can Growth Be Sustained as Statin Patents Expire?

Table of Contents

Statins and the Cardiovascular Market

Overview of Dyslipidemia

• Lipoproteins in the Blood
• Dyslipidemia and Cardiovascular Disease
• Prevalence of Dyslipidemia

Current Treatments

• Statins
• Fibrates
• Cholesterol Modulators
  • Bile Acid Sequestrants
  • Nicotinic Acid (Niacin)
  • Cholesterol Absorption Inhibitors
• Combination Products

Current Market Status

• United States
• Europe
• Japan

Key Patent Expiries

Agents in Development

• PPAR Agonists
• Cholesterol Modulators
  • CETP Inhibitors
  • ACAT Inhibitors
  • Nicotinic Acid Antagonists
  • Squalene Synthetase Inhibitors
• Combination Products
• Lp-PLA2 Inhibitor
• Statins

Market Outlook

• United States
• Europe
• Japan